Cart
sales@molnova.com
Ligustroflavone
CAS No. 260413-62-5
Ligustroflavone( Nuezhenoside )
Catalog No. M18322 CAS No. 260413-62-5
Ligustroflavone has anti-inflammatory activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 87 | In Stock |
|
| 10MG | 147 | In Stock |
|
| 25MG | 248 | In Stock |
|
| 50MG | 357 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLigustroflavone
-
NoteResearch use only, not for human use.
-
Brief DescriptionLigustroflavone has anti-inflammatory activity.
-
DescriptionLigustroflavone has anti-inflammatory activity.
-
In Vitro——
-
In Vivo——
-
SynonymsNuezhenoside
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number260413-62-5
-
Formula Weight724.67
-
Molecular FormulaC33H40O18
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (172.49 mM)
-
SMILESc1(cc(=O)c2c(cc(cc2o1)O[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O[C@@H]1O[C@H]([C@@H]([C@H]([C@H]1O)O)O)C)O)O)CO[C@@H]1O[C@H]([C@@H]([C@H]([C@H]1O)O)O)C)O)c1ccc(cc1)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Pieroni A,et al. Isolation and structure elucidation of ligustroflavone, a new apigenin triglycoside from the leaves of Ligustrum vulgare L. Pharmazie. 2000 Jan;55(1):78-80.
molnova catalog
related products
-
Ezabenlimab
Ezabenlimab (BI-754091) is an anti-PD-1 monoclonal antibody (mAb) with a binding constant (Kd) of 6 nM in CHO cells.
-
Ru-32514
Ru-32514 is a benzodiazepine receptor agonist that partially reverses stress-induced arousal in mice and is used in the study of neurological disorders.
-
RCM-1
RCM-1 is an inhibitor of FOXM1. RCM-1 inhibits cellular proliferation via the increasing duration of cell cycle and mitosis in human and mouse cancer cell lines in vitro. RCM-1 inhibits colony formation of cancer cells in vitro in a dose-dependent manner. RCM-1 inhibits the migration of cancer cells in vitro in a dose-dependent manner.
